These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 339055)

  • 1. Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.
    Wood AW; Levin W; Lu AY; Ryan D; West SB; Yagi H; Mah HD; Jerina DM; Conney AH
    Mol Pharmacol; 1977 Nov; 13(6):1116-25. PubMed ID: 339055
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
    Golan MD; Bücker M; Schmassmann HU; Raphael D; Jung R; Bindel U; Brase HO; Tegtmeyer F; Friedberg T; Lorenz J; Stasiecki P; Oesch F
    Drug Metab Dispos; 1980; 8(3):121-6. PubMed ID: 6104571
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.
    Wood AW; Levin W; Lu AY; Yagi H; Hernandez O; Jerina DM; Conney AH
    J Biol Chem; 1976 Aug; 251(16):4882-90. PubMed ID: 821945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutagenic action of benz(a)pyrene and its metabolites in the in vitro Salmonella typhimurium-microsomes test system].
    Tolcheev IuD; Khitrovo IA; Kobliakov VA
    Biull Eksp Biol Med; 1980 Aug; 90(8):208-10. PubMed ID: 6996763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative benzo[a]pyrene metabolite patterns in fish and rodents.
    Melius P
    Natl Cancer Inst Monogr; 1984 May; 65():387-90. PubMed ID: 6087145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epoxide hydratase inducer trans-stilbene oxide shifts the metabolic epoxidation of benzo(a)pyrene from the bay- to the K-region and reduces its mutagenicity.
    Bücker M; Golan M; Schmassmann HU; Glatt HR; Stasiecki P; Oesch F
    Mol Pharmacol; 1979 Sep; 16(2):656-66. PubMed ID: 390362
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual role of epoxide hydratase in both activation and inactivation of benzo(a)pyrene.
    Bentley P; Oesch F; Glatt H
    Arch Toxicol; 1977 Dec; 39(1-2):65-75. PubMed ID: 341851
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic activation of dibenzo(a,h)anthracene and its dihydrodiols to bacterial mutagens.
    Wood AW; Levin W; Thomas PE; Ryan D; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Jul; 38(7):1967-73. PubMed ID: 350381
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C; Brun G; Hautefeuille A; Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
    Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Influence of epoxide hydrase inhibitors on mutagenic effects of reactive metabolites generated in situ from benzo(a)pyrene.
    Glatt HR; Oesch F
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R24. PubMed ID: 4152359
    [No Abstract]   [Full Text] [Related]  

  • 15. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of benzo[a]pyrene. VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides.
    Thakker DR; Yagi H; Akagi H; Koreeda M; Lu AH; Levin W; Wood AW; Conney AH; Jerina DM
    Chem Biol Interact; 1977 Mar; 16(3):281-300. PubMed ID: 862130
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants.
    Benson AM; Batzinger RP; Ou SY; Bueding E; Cha YN; Talalay P
    Cancer Res; 1978 Dec; 38(12):4486-95. PubMed ID: 363262
    [No Abstract]   [Full Text] [Related]  

  • 20. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites.
    Oesch F; Raphael D; Schwind H; Glatt HR
    Arch Toxicol; 1977 Dec; 39(1-2):97-108. PubMed ID: 341853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.